Lipoprotein News and Research

RSS

A lipoprotein is a biochemical assembly that contains both proteins and lipids. The lipids or their derivatives may be covalently or non-covalently bound to the proteins.

From espresso to filter coffee, brewing may shape what reaches your gut

A focused narrative review traces how caffeine, chlorogenic acids, and coffee fibers move through the gut and interact with microbes. The authors identify plausible links between the microbiome and liver health, but human studies have not shown that microbiome changes cause coffee’s reported metabolic benefits.

28 Sep 2026

Semaglutide cuts major heart events, but researchers still cannot fully explain why

In adults with overweight or obesity and established cardiovascular disease but no diabetes, semaglutide reduced major adverse cardiovascular events by 20%, while changes in measured cardiovascular risk factors could not fully explain the benefit with certainty. The findings suggest that additional, as-yet unidentified biological pathways may contribute to semaglutide’s cardiovascular protection.

27 Sep 2026

Advances in chemistry and delivery are taking oligonucleotide medicines beyond rare diseases

A review in Cell Reports Medicine examines how advances in oligonucleotide chemistry and delivery have established ASOs and RNA interference therapies as a class of genetic medicines, with 21 oligonucleotides approved at the time of writing. It also identifies extrahepatic delivery, safety, target validation, individualized treatment, and data quality as priorities as the field expands into common diseases and explores AI-assisted development.

24 Sep 2026

Children who ate healthier plant foods had slightly lower blood pressure later

Researchers followed 3,990 Dutch children for an average of 1.6 years and found that higher healthful plant-based diet scores were associated with modestly lower blood pressure and total cholesterol. Children with higher unhealthful plant-based diet scores had lower estimated food costs and distinct metabolite profiles, while healthful scores showed no clear cost association.

22 Sep 2026

Regular exercisers show distinct metabolic and immune signatures in blood

Researchers compared blood samples from 40 regular exercisers and 46 sedentary adults and found differences in metabolites, blood chemistry, and immune cell gene activity. The patterns suggested greater fatty acid use and altered immune signaling among exercisers, but the study could not establish that exercise caused these differences.

21 Sep 2026

Several cups of coffee a day showed no clear diabetes link over 10 years

Researchers followed 1,158 adults in Italy for 10 years, comparing those who drank at least two to three cups of coffee daily with those who drank none. They found no statistically significant difference in new cases of impaired fasting glucose or type 2 diabetes, but the small non-consumer group limits how confidently the study can rule out a difference in risk.

21 Sep 2026

Sex-specific biological clocks reveal how aging differs across the body in women and men

Researchers developed 38 sex-specific biological aging clocks across 15 organ systems, finding differences between females and males in genetic architecture, molecular signatures, disease associations, and mortality patterns. Brain aging clocks were linked to progression from mild cognitive impairment to Alzheimer’s disease in both sexes and to sex-dependent cognitive trajectories among solanezumab-treated A4 participants, while the authors stressed that sex-pooled and sex-interaction models remain complementary approaches.

17 Sep 2026

Fermented dairy was linked to lower mortality, but the pattern shifted at higher intakes

Analysis of 37,366 US adults found that fermented dairy consumption was associated with lower all-cause and cardiovascular mortality, with consumers showing adjusted hazards 18% and 20% lower, respectively, than non-consumers. Dose-response analyses indicated that the inverse association was concentrated at intakes below about 150 grams per day, while the observational study could not establish causality.

16 Sep 2026

Scientists tested how much whole grain makes a difference. The answer was not simply “more”

A meta-analysis of 87 randomized trials found that increasing whole-grain intake was associated with improvements in several cardiometabolic risk factors, although many individual changes were small or clinically unimportant. Dose-response analyses suggested that the magnitude of the effects varied by outcome and intake level, with limited evidence at very high intakes.

16 Sep 2026

Eating four to six wholegrain servings daily protects heart health

Eating four to six servings of wholegrain each day reduces several major risk factors for cardiovascular disease, according to a new study published in the European Heart Journal today (Wednesday).

16 Sep 2026

An 8-hour eating window stood out for weight loss, but the full picture is more complicated

A pooled analysis of individual data from five time-restricted eating trials involving 124 adults linked shorter eating windows with modestly greater weight loss. Eight-hour TRE was associated with greater weight loss than 12-hour TRE and controls, while cardiometabolic outcomes showed no consistent relationship with eating-window duration and several weight associations weakened after adjustment.

14 Sep 2026

Early studies hint that ketones may affect pathways linked to PTSD

An integrative review found that ketogenic therapy may influence metabolic, inflammatory, oxidative stress, and neurotransmitter pathways implicated in PTSD, with animal studies and small human studies reporting early signs of symptom improvement. Human evidence remains limited to very small cohorts, case reports, and pilot studies, and controlled trials have yet to establish clinical efficacy.

11 Sep 2026

Why a shorter eating window may not mean better metabolic health

In a nationally representative cross-sectional study of 16,973 Korean adults, researchers identified three distinct eating patterns based on the timing and distribution of daily energy intake. Eating later within a shorter daily window was associated with higher odds of metabolic syndrome, elevated blood pressure, triglycerides, and fasting glucose, while frequent grazing showed a mixed metabolic profile.

8 Sep 2026

GLP-1 drugs have benefits beyond weight loss. Could microdoses preserve them?

A narrative review suggests GLP-1-based therapies deliver metabolic, cardiovascular, renal, and other systemic benefits, raising interest in whether lower fractional doses could improve tolerability and treatment continuity. However, direct evidence for GLP-1 microdosing remains extremely limited, and researchers say prospective studies are needed to determine whether lower doses preserve long-term benefits.

1 Sep 2026

Breastmilk from cannabis users showed differences, but cannabis may not be the whole story

A narrative review found that maternal cannabis use may be associated with differences in breastmilk fat, protein, lactose, and the immune factor secretory immunoglobulin A, but evidence comes primarily from only two human studies and remains limited and inconsistent. The authors stress that maternal diet, food security, socioeconomic circumstances, and other forms of adversity could confound these associations and should be incorporated into future research.

31 Aug 2026

The scale told a similar story across three diets. The liver told a different one

In a randomized controlled trial of people with metabolically unhealthy obesity, approximately 10% weight loss improved insulin sensitivity and several cardiometabolic measures across ketogenic, Mediterranean, and very-low-fat plant-forward diets. However, the very-low-carbohydrate ketogenic diet produced larger improvements in hepatic insulin sensitivity and greater reductions in liver fat and several glucose and insulin measures than the higher-carbohydrate diets.

31 Aug 2026

Starting statins early after diabetes diagnosis linked to lower dementia risk

Early initiation of statins after diagnosis of type 2 diabetes was associated with a lower risk of dementia, according to a study presented today at ESC Congress 2026 and published in The Lancet Regional Health – Europe.

30 Aug 2026

Immediate evolocumab use after heart attack improves cholesterol goals but not survival

Immediate initiation of evolocumab after a heart attack significantly improved low-density lipoprotein cholesterol (LDL-C) goal achievement, but an early reduction in all-cause death or unplanned cardiovascular hospitalization was not observed compared with standard care.

29 Aug 2026

Pacibekitug safely reduces inflammatory biomarkers in kidney disease patients

The interleukin-6 (IL-6) antibody, pacibekitug, produced sustained reductions in inflammatory biomarkers in patients with chronic kidney disease at high inflammatory risk, according to results from the phase II TRANQUILITY trial presented in a Hot Line session today at ESC Congress 2026.

29 Aug 2026

Scientists reviewed 20 edible and medicinal fungi for clues to better prebiotics

A review of 20 non-toxic edible and medicinal fungal species found that their polysaccharides can resist digestion, interact with gut microbes, and influence microbial metabolites linked to intestinal and metabolic health. The evidence suggests potential benefits for conditions including colitis, type 2 diabetes, and obesity, although most findings currently come from laboratory and animal studies.

27 Aug 2026

Lipoprotein News and Research

Further Reading

From espresso to filter coffee, brewing may shape what reaches your gut

Semaglutide cuts major heart events, but researchers still cannot fully explain why

Advances in chemistry and delivery are taking oligonucleotide medicines beyond rare diseases

Children who ate healthier plant foods had slightly lower blood pressure later

Regular exercisers show distinct metabolic and immune signatures in blood

Several cups of coffee a day showed no clear diabetes link over 10 years

Sex-specific biological clocks reveal how aging differs across the body in women and men

Fermented dairy was linked to lower mortality, but the pattern shifted at higher intakes

Scientists tested how much whole grain makes a difference. The answer was not simply “more”

Eating four to six wholegrain servings daily protects heart health

An 8-hour eating window stood out for weight loss, but the full picture is more complicated

Early studies hint that ketones may affect pathways linked to PTSD

Why a shorter eating window may not mean better metabolic health

GLP-1 drugs have benefits beyond weight loss. Could microdoses preserve them?

Breastmilk from cannabis users showed differences, but cannabis may not be the whole story

The scale told a similar story across three diets. The liver told a different one

Starting statins early after diabetes diagnosis linked to lower dementia risk

Immediate evolocumab use after heart attack improves cholesterol goals but not survival

Pacibekitug safely reduces inflammatory biomarkers in kidney disease patients

Scientists reviewed 20 edible and medicinal fungi for clues to better prebiotics

Latest eBooks

Editorial Focus eBook - Spatial and single-cell omics (1st edition)

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Industry Focus eBook - Cell biology (5th edition)

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics